IDflu

Medicinal product

(Invented) name

IDflu

Active substance (s)

A/California/7/2009 (H1N1)pdm09 panaši padermė (A/California/7/2009, NYMC X-179A) /Į A/Hong Kong/4801/2014 (H3N2) panaši padermė (A/Hong Kong/4801/2014, NYMC X-263B)/Į B/Brisbane/60/2008 panaši padermė (B/Brisbane/60/2008, laukinis tipas)

Strength

15 µg HA/15 µg HA/15 µg HA

Pharmaceutical form

injekcinė suspensija

Route (s) of administration

leisti į odą

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

J07BB02, influenza, inactivated, split virus or surface antigen

Marketing authorisation holder

Sanofi Pasteur S.A., Prancūzija

Date of authorisation

2009-02-24

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Suspension for injection	0.1 ml
A/California/7/2009 (H1N1)pdm09 panaši padermė (A/California/7/2009, NYMC X-179A)	15 µg HA
Į A/Hong Kong/4801/2014 (H3N2) panaši padermė (A/Hong Kong/4801/2014, NYMC X-263B)	15 µg HA
Į B/Brisbane/60/2008 panaši padermė (B/Brisbane/60/2008, laukinis tipas)	15 µg HA

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To
34149	36504	1036504	užpildytas švirkštas	0,1 ml N1	Receptinis	EU/1/08/507/004	Netiekiama	-	-	No	-	-
34150	36505	1036505	užpildytas švirkštas	0,1 ml N10	Receptinis	EU/1/08/507/005	Netiekiama	-	-	No	-	-
34151	36506	1036506	užpildytas švirkštas	0.1 ml N20	Receptinis	EU/1/08/507/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2018-03-21	Išregistruotas
2009-02-24	Registruotas